Patent · US Active

N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor

US8710059B2 · kind B2 · utility

3Cited by

5References

20Claims

0Family size

Assignees

Abbott Laboratories · US
Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

Andreas Haupt · Ludwigshafen, DE
Frauke Pohlki · Wiesbaden, DE
Liliane Unger · Ludwigshafen, DE
Ana-Lucia Relo · Ludwigshafen, DE
Karsten Wicke · Ludwigshafen, DE
Min Zhang · 安丰镇, CN

Key dates

Filing date	Nov 1, 2011
Grant date	Apr 29, 2014
Priority date	—
Expiry date	Nov 1, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D243/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to N-Phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds of formula Iwherein the variables have the meanings given in the claims and the description, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating diseases that respond to modulation of the serotonin 5-HT6 receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.